Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research report that presented a favorable analysis, noting that the company is anticipating a number of key catalysts in the second half of 2025, including progress on its current phase 3 FLASH2 trial of HyBryte(TM) for the…
Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology drug developer, announced the launch of a new AI-powered module within its RADR(R) platform to predict the efficacy of combination therapies involving DNA-damaging agents (DDAs) and DNA damage response inhibitors (DDRis). Backed by a peer-reviewed analysis of 221 clinical trials, the tool enables precise, biomarker-guided design of cancer…
Newton Golf Company (NASDAQ: NWTG) is realizing triple-figure revenue growth after the launch of its newest shaft family. The company’s CEO Greg Campbell was quoted in a recent article that highlights the growing interest in Fast Motion. “When we launched the Newton Motion shaft, our goal was to engineer performance that speaks for itself,” Campbell states.…
FAVO Capital (OTC: FAVO) is positioned as inflationary pressures and elevated interest rates strain traditional financing channels and small and medium-sized businesses (“SMBs”) increasingly seek alternative funding sources to maintain liquidity and drive growth. The company was featured in a recent article that discussed the fintech-driven private credit firm built specifically to meet the evolving needs…
Nutriband (NASDAQ: NTRB) was recently featured on the Smart Money Circle Show, where Serguei Melnik, NTRB’s founder and president, unveiled his no-nonsense approach to biotech entrepreneurship. Standing in stark contrast to the conventional playbook are his grounded tone and unwavering focus on long-term value. An article discussing this reads, “Unlike most early-stage biotech companies, Nutriband generates revenue…
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic milestones. President and CEO Dr. Christopher J. Schaber highlighted upcoming data readouts for lead candidates, including Phase 3 FLASH 2 results for HyBryte(TM) (synthetic hypericin) in cutaneous T-cell lymphoma expected…
HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. “HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical decisions outside the confines of a traditional medical setting. Its patented approach not only delivers similar, but not identical, accuracy…
BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset Management, LLC. In exchange for exclusive power rights, BluSky AI issued 20 million shares of restricted stock. The company also…
Newton Golf Company (NASDAQ: NWTG) is positioned for opportunity as it brings innovation to golf players seeking performance gains. The company recently launched its latest product: the Fast Motion shaft family, aiming to redefine performance standards and capitalize on the growing appetite for cutting-edge golf technology. “Newton Golf’s new Fast Motion shaft exemplifies how a company…
As the private credit market continues to evolve, FAVO Capital (OTC: FAVO) is positioned to capitalize on emerging opportunities. “FAVO stands out as a leading private credit provider, specializing in delivering fast, efficient and personalized funding solutions to small and mid-sized businesses (‘SMBs’) across the United States and the Dominican Republic. Leveraging advanced technology and data-driven underwriting…
Solowin Holdings (NASDAQ: SWIN) is focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. “Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin is licensed by the Hong Kong Securities and Futures Commission and offers access to a full suite of financial services…
Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. CEO Gareth Sheridan called the inclusion a reflection of market recognition and momentum behind the company’s AVERSA pipeline, particularly AVERSA Fentanyl, which has potential peak annual U.S.…
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) has reached a mutual agreement with Empresa Minera Villegas S.R.L. to amend the payment terms for acquiring 100% interest in the Iska Iska silver-tin polymetallic project in southern Bolivia. Of the remaining US$4.45 million owed, US$1.8 million in exploration spending on the adjacent Mina Casiterita property will…
Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections in the face of escalating antibiotic resistance. The company’s SGX943 therapy “is based on dusquetide, an Innate Defense Regulator (‘IDR’) that modulates the body’s immune response rather than directly targeting bacteria. By enhancing the innate…
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer therapies. “Lantern Pharma’s AI-driven RADR(R) platform integrates over 200 billion oncology-specific data points and underpins…